Atlas Trials

Study Evaluating Betrixaban in Pediatric Participants

Clinical trial NCT03346083 · TERMINATED

Trial details

NCT number
NCT03346083
Sponsor
Alexion Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
VTE Prophylaxis
Start date
2018-07-13
Primary completion
2019-10-08
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.